These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7237821)

  • 1. Abnormality of oral ursodeoxycholic acid tolerance test in the Dubin-Johnson syndrome.
    Kawasaki H; Yamanishi Y; Kishimoto Y; Hirayama C; Ikawa S; Kuchiba K; Kondo T
    Clin Chim Acta; 1981 Apr; 112(1):13-9. PubMed ID: 7237821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid oral tolerance test in patients with constitutional hyperbilirubinemias and effect of phenobarbital.
    Ohkubo H; Okuda K; Iida S; Makino I
    Gastroenterology; 1981 Jul; 81(1):126-35. PubMed ID: 7239112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
    Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids.
    Corpechot C; Ping C; Wendum D; Matsuda F; Barbu V; Poupon R
    Am J Gastroenterol; 2006 Oct; 101(10):2427-32. PubMed ID: 16952291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ursodeoxycholic acid tolerance test in patients with digestive disease.
    Yamanishi Y; Kishimoto Y; Kawasaki H; Hirayama C; Ikawa S
    Gastroenterol Jpn; 1981; 16(5):472-7. PubMed ID: 7327385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bile acids and oral ursodeoxycholic acid tolerance test in the diagnosis of esophageal varices.
    Kadohara M; Kawasaki H; Hirayama C
    Gastroenterol Jpn; 1987 Oct; 22(5):614-20. PubMed ID: 3678732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change of serum bile acids levels after administration of UDCA and test meals (author's transl)].
    Inaguma H
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):289. PubMed ID: 7098117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
    Yanaura S; Izuka A; Ishikawa S
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of serum bile acid levels (TBA, CG) in liver disease-difference between fasting and UDCA oral loading (author's transl)].
    Hino K; Yamamoto S; Yamashita S; Fukushima K; Ohashi K
    Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2197. PubMed ID: 7328844
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic value of oral bile acid tolerance test (author's transl)].
    Matsumoto H; Masamune O; Nunode Y; Ohshiba S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Jul; 78(7):1380-7. PubMed ID: 7311082
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of [14C]ursodeoxycholic acid in the rat.
    Parquet M; Rey C; Groussard M; Infante R
    Biochim Biophys Acta; 1981 Aug; 665(2):299-305. PubMed ID: 7284427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal-systemic spill-over of bile acids: a study of mechanisms using ursodeoxycholic acid.
    Miescher G; Paumgartner G; Preisig R
    Eur J Clin Invest; 1983 Dec; 13(6):439-45. PubMed ID: 6416860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile salt transport in the Dubin-Johnson syndrome.
    Douglas JG; Beckett GJ; Percy-Robb IW; Finlayson ND
    Gut; 1980 Oct; 21(10):890-3. PubMed ID: 7439808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
    Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
    Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial nonhemolytic jaundice with free and conjugated hyperbilirubinemia, elevated serum bile acids, and liver pigmentation.
    Mihas AA; Kirby JD; Hirschowitz BI
    South Med J; 1979 Aug; 72(8):1014-6. PubMed ID: 472798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance and limitations of oral UDCA loading in liver function test].
    Matsuzaki Y; Osuga T; Shoda J; Imawari M; Mitamura K
    Nihon Rinsho; 1984 Jul; 42(7):1671-6. PubMed ID: 6492410
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
    Colombo C; Setchell KD; Podda M; Crosignani A; Roda A; Curcio L; Ronchi M; Giunta A
    J Pediatr; 1990 Sep; 117(3):482-9. PubMed ID: 2391610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unconjugated bilirubin kinetics in Dubin-Johnson syndrome.
    Kawasaki H; Kuchiba K; Kondo T; Kimura N; Hirayama C
    Clin Chim Acta; 1979 Feb; 92(1):87-92. PubMed ID: 421352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.